Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Bio Green Med Solution Q3 2026 Results: Net Loss of $449K, Loss Narrows

Bio Green Med Solution, Inc. is undergoing a significant business combination with Future NRG Sdn. Bhd. (FNRG), which will result in FNRG shareholders owning over 99% of the combined company. The company recently deconsolidated its former subsidiary, Cyclacel Limited, following a creditors voluntary liquidation and has pivoted its business focus through various asset sales and exchange agreements.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.50.1
Profit before tax-0.4-1.0
Net income-0.4-1.0
EPS (diluted, $ a share)$-0.07$-1.31

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+400.0%
Operating margin-104.0%
Source

10-Q filed with the SEC, NASDAQ: BGMS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Bio Green Med Solution, Inc.: key numbers

Share price
$0.6502Close, Nov 16
Market cap
$4.31M
Shares outstanding
6.62MLatest SEC cover page
Sector
Trade & Services
Industry
Wholesale-Durable Goods, NECSIC 5099

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Bio Green Med Solution, Inc.

All →
5:01 PM ET 8-K
Financial Results

Bio Green Med Solution Financial Results

Bio Green Med Solution reported Q3 2026 financial results, highlighting a significant increase in fire safety product revenue to $454,000 and a narrowed net loss of $0.4 million. The company also announced that its Form S-4 for the proposed business combination with Future NRG Sdn. Bhd. has been declared effective, with a shareholder vote planned for November 2026.

Term
Q3 2026

“During the third quarter, our fire safety business generated $454,000 in product revenue, compared to $81,000 in the prior-year period, and yielded a gross margin of approximately 25%, while our net loss narrowed to $0.4 million from $1.0 million in the prior-year period.”

Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director

“We also reduced general and administrative expenses by 37% year over year and ended the quarter with $3.5 million in cash and cash equivalents.”

Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director
5:29 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Bio Green Med Solution Nasdaq/NYSE Compliance Notice

Bio Green Med Solution received a deficiency notice from Nasdaq on October 29, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 27, 2027, to regain compliance and is considering a reverse stock split as a potential remedy in connection with its pending business combination with Future NRG Sdn. Bhd.

Counterparty
Nasdaq Stock Market LLC
Term
180 days
4:06 PM ET 8-K
Dividend

Bio Green Med Solution Dividend

Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. The dividend is payable on November 1, 2026, to stockholders of record as of October 26, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.